| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9319344 | European Urology | 2005 | 6 Pages |
Abstract
The CXCR4 antagonist 4F-bTE has the potential to inhibit expression of the metastatic phenotype and may provide therapeutic value to patients.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
M. Retz, S.S. Sidhu, J. Lehmann, H. Tamamura, N. Fujii, C. Basbaum,